OPN1SW and Parkinson disease: Indeed, it should be considered that results from the preclinical studies in different PD cellular and animal models have shown the protective effects of different CB2 receptor selective agonists, such as AM1241, HU-308, JWH-133, BCP, and GW842166x [49,61,62,64,65,66,67,69].